Crossmark

NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.02.017

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

de Queiroz, Gustavo Nery

Lima, Keli

de Miranda, Livia Bassani Lins

Rego, Eduardo Magalhães

Traina, Fabiola

Machado-Neto, João Agostinho https://orcid.org/0000-0002-2937-8109
Funding

Funding for this research was provided by:

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado de São Paulo (2023/01331-2, 2021/11606-3, 2022/03316-8, 2020/12842-0)
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-03-13
More Information

This article is maintained by: Elsevier

Article Title: NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.02.017

Content Type: article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.